C hronic pulmonary hypertension (PH), in all its forms, is characterized by robust fibroproliferative changes in pulmonary arteries. 1,2 Importantly, one of the most consistent findings in experimental models of PH and in models of vascular injury and hypertension in the systemic circulation is early and dramatic remodeling of the perivascular layer, namely adventitia. The vascular adventitia acts as a biological processing center for the retrieval, integration, storage, and release of key regulators of vessel wall function. During the remodeling process, the principal cell type of the vascular adventitia, fibroblast, undergoes profound phenotypic changes characterized by heightened proliferative, migratory, fibrotic, and inflammatory activity. 3-10 These observations raise the possibility of the emergence and expansion of adventitial fibroblasts that have lost their ability to limit stimulus-induced proliferation and cytokine production. 11 Experimental evidence suggests that
the stable changes in the highly activated phenotype of adventitial fibroblasts from the PH vessel are caused by epigenetic modifications such as might occur in response to altered histone acetylation, DNA methylation, and changes in microR-NA (miRNA or miR) expression profiles. 10, [12] [13] [14] Editorial, see p 5
miRNAs are classes of small noncoding RNAs that can regulate gene expression by binding to the 3′ untranslated region (3′ UTR) of target mRNA to cause degradation or translational repression. 15 miRNAs play important roles in the regulation of gene expression, developmental processes, cell differentiation, cell proliferation and migration, apoptosis, and stress responses. 16, 17 Aberrant miRNA expression is directly related to initiation and progression of pathophysiological processes, including diabetes mellitus, cancer, and cardiac hypertrophy. [18] [19] [20] Furthermore, miRNAs have been implicated in atherogenesis, control of vascular tone, and hypertension, as well as neointimal formation. 18, [21] [22] [23] Recent studies also implicate a role for miR-NAs in the complex pathology and molecular dysregulation that characterizes PH. [23] [24] [25] [26] [27] [28] Several miRNA target genes, including BMPR2, RhoB, SHP2, NFAT, and Mst1, have been predicted to be highly enriched in PH-associated pathways, suggesting extensive miRNA-regulated control of this disease. [23] [24] [25] [28] [29] [30] However, all studies on miRNAs in PH disease process to date have exclusively examined changes in endothelial and smooth muscle cells, whereas the role of miRNAs in controlling the phenotype of adventitial fibroblast remains undefined.
Our previous findings of dramatic differences in the proliferative and inflammatory characteristics of adventitial fibroblasts from the chronically hypertensive pulmonary vessel wall compared with control prompted us to evaluate more thoroughly the signaling networks that control this cell phenotype. Our recent studies, using Affymetrix array analysis as well as RNA sequencing (Ingenuity Systems, Redwood City, CA; Bio-Function Analysis), highlighted signaling networks upregulated in constitutively activated fibroblasts from hypertensive neonatal calves, including proliferation, inflammation, glioma cells, and neurite outgrowth (Stenmark K, unpublished data, 2013) . We were particularly interested in links between proliferation and glioma cell signaling networks because previous studies in glioblastoma cells have demonstrated an important contribution of reduced miR-124 expression in the acquisition of a highly proliferative, invasive phenotype. 31 Downregulation of miR-124 has also been documented in carcinogenesis in other cell systems 32, 33 and in rheumatoid arthritis where altered expression of miRNAs in general and miR-124 specifically have been shown to regulate cell proliferation and inflammation in synovial fibroblasts. 34, 35 Studies in cancer and neuronal cells have began to establish the downstream targets of miR-124, which may associate with proliferation or other aspects of activated cell phenotype, such as Sox9, Jag1, polypyrimidine tract-binding protein 1 (PTBP1), small C-terminal domain phosphatase 1, ephrin-B1, NfatC3, and monocyte chemotactic protein-1 (MCP-1). 27, 36, 37 PTBP1 is especially interesting because of its effects on Notch signaling and other aspects of proliferation in cancer cell types. 38 We thus sought to determine whether the activated (highly proliferative, promigratory, and proinflammatory) phenotype of pulmonary adventitial fibroblasts was controlled by suppression of miR-124 and subsequent increases in PTBP1. We determined the effects of restoration of miR-124 expression on the activated fibroblast phenotype using cells and tissues from both large mammalian experimental animal (calf) and humans to better understand mechanisms controlling adventitial fibroblast function in human PH disease process.
Methods
Details are provided in the Online Data Supplement.
Animals
Neonatal calves, Wistar-Kyoto rats, and C57BL/6 mice with hypoxiainduced PH were used in the study.
Patient Characteristics
Human lung tissues from subjects with idiopathic pulmonary arterial hypertension (IPAH) or donors were obtained during lung transplantation. Clinical information on patients is summarized in Online Table I .
Cell Culture
Bovine pulmonary artery adventitial fibroblasts were isolated from control and hypoxic hypertensive calves. Human pulmonary artery fibroblasts were derived from patients with idiopathic PH or from patients undergoing lobectomy or pneumonectomy.
Cell proliferation was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. Cell migration was evaluated by scrape assay.
Real-Time Reverse Transcriptase-Polymerase Chain Reaction
Total RNA was extracted and reverse-transcribed to cDNA as described in online-only Data Supplement. The intron-spanning primers were designed using sequence information from the National Center for Biotechnology Information database (Online Table II ). Results are presented as fold changes in gene expression calculated using the 2-ΔΔ cycle threshold method.
Cell Transfection
Transfection was performed with 50 nmol/L of miR-124 mimic, scramble, anti-miR, short interfering RNAs (scramble), or short interfering RNA targeting PTBP1, PTBP2, and phosphatase and tensin homolog (PTEN) (Online Table II ). Total RNA/miRNA was extracted 48 hours after transfection using mirVana miRNA isolation kit.
Luciferase Reporter Assay
Wild-type or mutant PTBP1 reporter constructs were cotransfected with miR-124 (50 nmol/L) into cells using DharmaFECT Transfection Reagents (Dharmacon). Firefly and Renilla luciferase activities were measured using a Dual-Luciferase Assay (Promega, 
Statistics
Values are expressed as fold-change mean±SEM. Student t test and 1-way ANOVA were used for statistical analysis. Differences with P<0.05 were considered statistically significant.
Results

miR-124 Is Decreased in Fibroblasts Exhibiting a Highly Proliferative and Promigratory Phenotype
Pulmonary adventitial fibroblasts derived from calves with severe PH (PH-Fibs) and from humans with IPAH (IPAH-Fibs) demonstrated markedly enhanced proliferative (in the absence of serum-derived growth factors) and migratory capabilities compared with fibroblasts derived from control calves (CO-Fibs) or human donors (HCO-Fibs; Figure 1A -1C). These highly proliferative and promigratory PH-Fibs/IPAH-Fibs exhibited significantly decreased expression of miR-124 compared with corresponding control fibroblasts ( Figure 1D ). The observed marked decrease in miR-124 expression in PH-/IPAH-Fibs was not because of proliferation-stimulating culture conditions because decreased miR-124 levels were also observed in lung tissue of PH calves and in pulmonary arteries isolated by laser-assisted microdissection from human patients with IPAH ( Figure 1E ). Interestingly, no decrease in miR-124 expression was detected in chronically hypoxic male mouse or rat lung tissue or in sugen+hypoxia male mouse lungs, suggesting speciesspecific changes in miR-124 expression in PH (Online Figure I ).
Highly Proliferative and Migratory Fibroblast Phenotype Is Controlled by miR-124
To investigate the function of miR-124 in these highly activated fibroblasts, we transiently transfected mature miR-124 mimic, anti-miR-124, and scrambled mimic (as control) into both bovine and human PH-and CO-Fibs. Transfection efficiency was >95% as monitored by Cy5 oligonucleotides. Mature miR-124 expression in transfected cells was confirmed by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR; bovine, Figure 2A ; human, Figure 2E ). Transfection with miR-124 mimic did not result in cell death (Online Figure II) . Overexpression of miR-124 in PH-/IPAH-Fibs caused a significant time-dependent decrease in proliferation rate compared with PH-Fibs treated with the scrambled miRNA (bovine, Figure 2C ; human, Figure 2G ). Flow cytometric analysis demonstrated that overexpression of miR-124 contributed to a G1/S growth arrest in both PH-and CO-Fibs (Online Figure II ). Transfection of PH-/IPAH-Fibs with anti-miR-124 did not significantly affect their growth ( Figure 2C and 2G). However, transfection of slowly growing CO-/HCO-Fibs with anti-miR-124 significantly increased their proliferative capability, whereas transfection with miR-124 mimic slightly, yet significantly, decreased their proliferation (bovine, Figure 2B ; human, Figure 2F ).
Both the elevated promigratory capabilities of PH-/IPAH-Fibs and the moderate migratory capabilities of CO-/HCO-Fibs decreased on treatment with the miR-124 mimic ( Figure  2D and 2H). Notably, the migratory potential of PH-/IPAH-Fibs was decreased to the levels of untreated control cells. Anti-miR-124 treatment markedly increased the migratory potential of CO-/HCO-Fibs ( Figure 2D and 2H).
miR-124 Regulates Expression of Cell Cycle-Related Genes
We next sought to determine the mechanisms involved in miR-124 regulation of augmented PH-Fibs proliferation. We found that mRNA expression levels of Notch1, PTEN, FOXO3, p21Cip1, and p27Kip1 were reduced in PH-/IPAH-Fibs compared with control cells ( Figure 3A and 3B). Transfection with miR-124 mimic markedly increased mRNA expression levels of these genes in both hypertensive (PH-/IPAH) and control (CO-/HCO) fibroblasts. Furthermore, anti-miR-124 treatment caused a significant decline in mRNA expression of Notch1, PTEN, FOXO3, p21Cip1, and p27Kip1 in both cell types ( Figure 3A and 3B ).
PTBP1 Is a Direct Downstream Target of miR-124 in Adventitial Fibroblasts
miRNAs regulate gene expression by binding to target sites of mRNAs and causing their degradation or translational repression. As such, we sought to determine the targets-upstream of the cell cycle regulator genes PTEN, p21Cip1, and p27Kip1-that are increased in cells with low miR-124 expression. We first confirmed that miR-124 regulates FOXO3 and p21Cip1 expression in PH-Fibs via a PTEN-dependent pathway because short interfering (si)-PTEN-treated cells failed to upregulate FOXO3 and p21Cip1 in response to miR-124 overexpression (Online Figure III ). This suggested that direct miR-124 targets are located upstream of the PTEN pathway. Because Notch1 is a key regulator of PTEN and, as shown in Figure 3A and 3B, Notch1 is upregulated on overexpression of miR-124, we predicted that a direct target of miR-124 controls the Notch1 pathway in activated fibroblasts.
RT-PCR and Western blot analyses showed that PTBP1 expression levels were consistently increased in PH-/IPAH-Fibs compared with CO-/HCO-Fibs ( Figure 4A , 4B, 4D, and 4E). Immunostaining analysis demonstrated strong PTBP1 expression in the pulmonary artery adventitia (where fibroblasts reside) of severely hypertensive (bovine and human) but not control tissues ( Figure 4C and 4G). No increase in PTBP1 mRNA expression was noted in chronically hypoxic male mouse lungs (Online Figure I) . Quantitative RT-PCR analysis confirmed increased mRNA expression of PTBP1 in human IPAH pulmonary arteries compared with control arteries (obtained by laser-assisted microdissection; Figure 4F ). Transfection of both PH-/IPAH-Fibs and CO-/HCO-Fibs with miR-124 mimic decreased PTBP1 expression ( Figure 4A , 4B, and 4D), whereas anti-miR-124 treatment resulted in increased PTBP1 expression ( Figure 4A , 4B, and 4D).
To establish that miR-124 targets PTBP1 directly, a dualluciferase reporter assay was performed. The potential binding sites of miR-124 in the 3′ UTR of the bovine cPTBP1 mRNA were determined by TargetScan. To test the specific regulation of PTBP1 through the predicted binding sites, we cloned the PTBP1 3′ UTR and mutant sequence into a pmirGLO Dual-Luciferase miRNA target Expression Vector ( Figure 5A ). Luciferase activity of the wild-type pLuc-PTBP1 3′ UTR construct was significantly inhibited after transfection of miR-124 mimic into both CO-and PH-Fibs ( Figure 5B and 5C, respectively), whereas mutation of the miR-124 target site (deleted seed region or replaced A in the seed region) abolished miR-124 mimic effects, indicating that miR-124 specifically targets the PTBP1 3′ UTR.
Next, we treated PH-Fibs with siPTBP1 (to decrease PTBP1) and transfected these cells with pcDNA3.1-PTBP1 (to increase PTBP1; Online Figure IVA 
miR-124 Regulates Fibroblast Proliferation Through PTBP1
To determine whether PTBP1 mediates the antiproliferative effects of miR-124, we generated a PTBP1 expression vector without the 3′ UTR, pcDNA3.1-CMV-PTBP1, which encoded the full-length PTBP1 mRNA without the miR-124-binding site. We demonstrated that the vector encoded the PTBP1 protein and that cotransfection of miR-124 and pcDNA3.1-CMV-PTBP1 abrogated miR-124-induced PTBP1 downregulation, whereas miR-124 expression remained elevated (Online Figure V) . When PH-Fibs were cotransfected with pcDNA3.1-CMV-PTBP1 vector and miR-124 mimic, the antiproliferative effects of miR-124 were abrogated ( Figure 6A ).
To further investigate the signaling pathways involved in regulation of cell cycle-related genes by miR-124, we transiently cotransfected PH-Fibs with miR-124 and pcDNA3.1-CMV-PTBP1. Real-time PCR analysis demonstrated that induction of Notch1, PTEN, FOXO3, p21Cip1, and p27Kip1 expression by miR-124 was markedly attenuated (Figure 6B-6F ).
miR-124 Expression Is Controlled by Histone Deacetylases
To elucidate the stimulus responsible for decreased expression of miR-124 in PH-/IPAH-Fibs, we first tested hypoxia. Even prolonged (≤1 week) exposure of CO-Fibs to 3% hypoxia failed to decrease miR-124 expression (data not shown). Because hypermethylation of miR-124 was shown to be responsible for its suppression in cancer cells 40 and to be mediated through increases in EVI1 expression, we next evaluated EVI1 expression in PH-Fibs. No significant increases in EVI1 expression were detected (Online Figure VI) . Treatment of PH-Fibs with 5-aza-deoxycytidine (2, 5, and10 µmol/L) for 5 and 7 days also did not increase miR-124 (Online Figure VI) . Because histone deacetylase (HDAC) activity is required to maintain the activated PH-Fib phenotype 13 and miRNA expression can be modulated by acetylation, 41, 42 we next tested whether small molecule HDAC inhibitors can rescue miR-124 expression in PH-Fibs. As shown in Figure 7A 
miR-124 Controls HIF-2α Expression
Previous studies have documented that the hyperproliferative and promigratory phenotype of adventitial PH-Fibs is directly related to hypoxia-inducible factor (HIF)-2α expression and function. 43 We, therefore, evaluated whether miR-124 controlled expression of either HIF1α or HIF2α in fibroblasts. Under basal conditions, PH-/IPAH-Fibs constitutively overexpressed HIF2α compared with CO-/HCO-Fibs ( Figure 7B (a) and 7B(c)). No differences in HIF1α expression were observed between these cell types ( Figure 7B (b) and 7B(d)). Administration of miR-124 mimic significantly decreased mRNA expression levels of HIF2α in PH-/IPAH-Fibs and, although to a lesser extent, in CO-/HCO-Fibs ( Figure  7B (a) and 7B(c)). Conversely, anti-miR-124 treatment significantly increased HIF2α expression in PH-/IPAH-Fibs and only moderately in CO-/HCO-Fibs (Figure 7B(a) and 7B(c)).
miR-124 Directly Controls MCP-1 Expression in PH-Fibs
Bovine PH-Fibs (consistent with our previous observations), 13 as well as human IPAH-Fibs, demonstrated significantly increased expression levels of MCP-1 mRNA ( Figure 8A ) and protein (Online Figure VII) . Transfection with miR-124 mimic markedly decreased MCP-1 expression in both bovine ( Figure  8B ) and human ( Figure 8C ) fibroblasts and in both mRNA ( Figure 8 ) and protein (Online Figure VII) . Treatment with anti-miR-124 increased MCP-1 mRNA expression in CO-/HCO and PH-/IPAH fibroblasts (Figure 8B and 8C) and increased MCP-1 protein expression in CO-/HCO-Fibs (Online Figure VII) . To evaluate whether MCP-1 is a direct target of miR-124, we made a 3′ UTR MCP-1 promoter luciferase construct and observed that MCP-1 luciferase activity was significantly reduced in cells transfected with miR-124 mimic ( Figure 8D ). With use of manipulated reporter, transfection of miR-124 mimic no longer suppressed reporter activity ( Figure 8D ).
Because miR-124 gene expression is controlled by HDACs ( Figure 7A(a) ), we next tested whether HDAC inhibitors affect MCP-1 expression. Treatment of PH-/IPAH-Fibs with suberoylanilide hydroxamic acid (10 µmol/L) and apicidin (3 µmol/L) for 48 hours (for RT-PCR) and 72 hours (for Western blot) resulted in markedly decreased MCP-1 gene ( Figure 8E ) and protein ( Figure 8F ) expressions.
Discussion
Adventitial fibroblasts have been described to exhibit the earliest, most dramatic, and most sustained proliferative, fibrotic, and inflammatory responses to vascular stress and thus to play a key role in PH process. 4, 9, 10, 44, 45 Failure of activated fibroblasts to deactivate contributes to chronic inflammatory and fibrotic diseases. 9, 11 The mechanisms contributing to sustained activation of vascular adventitial fibroblasts in PH are yet to be defined. Numerous studies have shown that miRNAs are pivotal in the gene regulation process, playing important roles in controlling development, tissue-specific cell differentiation, cell proliferation and migration, apoptosis, and stress responses. 22, 23, 46, 47 However, it was previously not known whether changes in miRNA expression directly control the activated phenotype of pulmonary fibroblasts in PH.
The present study demonstrates an important role for miR-124 and its direct downstream target, the alternative splicing factor PTBP1, in the generation of epigenetically reprogrammed, activated adventitial fibroblast, characterized by heightened proliferative, migratory, and inflammatory properties from calves and humans with severe PH. Our studies are consistent with observations in cancer cells and rheumatoid arthritis synovial fibroblasts, diseases to which PH is thought to have similarities, where involvement of miR-124 in the regulation of cell proliferation, migration, and inflammation (MCP-1 production) has been documented. 31, [33] [34] [35] 48, 49 miR-124 is a frequently epigenetically silenced tumor-suppressive miRNA in cancer cells, which contributes to their proliferative and invasive capabilities. [31] [32] [33] 35, 50 Our study demonstrates that the proximal direct target of miR-124, the RNA-binding protein PTBP1, is a critical regulator of effects of miR-124 on fibroblast proliferation and migration, consistent with studies in some cancer cells and recently in vascular smooth muscle cells. 27, 31, 33 PTBP1 is a nucleic acid-binding protein, also known for its role in multiple aspects of mRNA life cycle and function, 51 including regulation of RNA processing and internal ribosome entry site-dependent translation, localization, stability, and translation. 52, 53 PTBP1 may also bind to DNA 54 and act as a transcription factor. 55 PTBP1 is strongly implicated in cancer initiation and progression, and removal of PTBP1 from tumor cells results in decreased cell proliferation and invasion. 49, 56, 57 Our study demonstrated that miR-124-mediated downregulation of cell proliferation was because of its effects on PTBP1 and that PTBP1 was a direct downstream target of miR-124 that can exert exquisite regulation of many downstream molecules important in cell proliferation, such as cell cycle-related genes Notch1, PTEN, FOXO3, p21Cip1, and p27Kip1 , as well as potentially in cell migration, where p27Kip1 has been implicated. 58 Our results also support the notion that miR-124, through direct regulation of PTBP1, controls Notch1 expression and subsequent downstream proliferative signaling pathways (AKT-2, p21Cip1, cyclin-dependent kinase 4 [CDK4]), likely through PTEN-related mechanisms. Reports in other cell systems demonstrated that Notch1 can function as an oncogene by regulating the PTEN/phosphatidylinositide 3-kinases/AKT pathway. 59, 60 A potential role for Notch1 in regulating proliferation has been demonstrated in some, but not all, studies in cancer cells. 61, 62 It should be noted, however, that the role of Notch signaling in cancer and in control of proliferation in other pathological conditions is highly dependent on the spatial and temporal context of Notch1 activation, as well as the status of other signaling pathways operating in cells. 63 Thus, highly proliferative PH-/IPAH-Fibs express a distinct phenotype that is dependent on decreased Notch1 signaling and downregulation of PTEN expression, similar to a phenotype of at least some cancer cells 64 and vascular smooth muscle cell phenotype achieved with PTEN knockdown in vivo. 65 The mechanisms contributing to stable decreases in miR-124 in PH/IPAH-Fibs are not fully understood. The ability of an initial stimulus, such as hypoxia, to engage an miRNA circuit could potentially result in stable changes in pulmonary fibroblasts, which persist even after the hypoxic stimulus is removed. However, in contrast to a recent report where acute hypoxia lead to an immediate reduction in miR-124, 35 we did not detect an ability of even prolonged exposure to hypoxia to drive a stable change in the control fibroblast phenotype toward the activated PH-Fibs phenotype or a reduction in miR-124 expression in these cells. Thus, the acquisition of stable, functional phenotypic changes likely requires the involvement of epigenetic processes such as might occur in response to altered histone acetylation, DNA methylation, and changes in miRNA expression profiles. 12 Histone-dependent packaging of genomic DNA into chromatin is a central mechanism for gene regulation. Expression of inflammatory genes, DNA repair genes, and proliferation genes is controlled by the degree of acetylation of histone and nonhistone proteins produced by histoneacetyltransferase and HDACs. [66] [67] [68] Several reports have documented such changes in HDAC activity in fibroblasts in rheumatoid arthritis and juvenile idiopathic arthritis, with specific increase in HDAC-1 activity. 68, 69 Our study demonstrates that HDAC inhibitors can restore miR-124 levels toward normal and reverse characteristics of the activated phenotype. These findings thus begin to explain the molecular basis for the constitutively activated fibroblast phenotype, which is critical in many aspects of the pulmonary vascular disease process. In the present study, apicidin, which selectively inhibits class I HDACs, led to significant miR-124 and concomitant decreases in PTBP1 expression. This is consistent with our previous reports that PH-Fibs exhibited significantly elevated catalytic activity of class I HDACs (HDAC-1, -2, and -3) and that selective inhibition of class I HDACs is sufficient to suppress pulmonary vascular remodeling and hypoxic PH. 13, 14, 70 Similarly, observations in cancer cells showed that HDAC inhibitors have important antitumor effects through modulation of miRNAs. 42 Reports in cancer have also suggested that epigenetic modulation of mRNA expression by HDAC inhibitors could be an important adjunctive treatment approach in cancer chemotherapy. 71 We showed that reduced miR-124 is associated with increased expression of HIF2α, but not HIF1α, and that restoring miR-124 expression can reduce HIF2α expression and attenuate cell proliferation. This is interesting because most previous studies in the pulmonary circulation have focused on the overexpression of HIF1α. 72 However, studies from several groups would suggest that HIF1α and HIF2α have distinct tissue and cell patterns of distribution and that both play critical but nonoverlapping roles in disease progression. 73 Eul et al 43 demonstrated that hypoxia-induced fibroblast proliferation requires HIF2α but not HIF1α activation. Ahmad et al 74 showed that, in the remodeling processes observed in PH, HIF2α plays a predominant role in the endothelial growth, whereas HIF1α plays roles in smooth muscle cell growth. Studies in cancer also support the idea that HIF2α is strongly related to the proliferative and invasive cell phenotype. The Simon laboratory showed that HIF2α in contrast to HIF1α promotes cell proliferation by enhancing the activity of c-myc. 75 HIF2α can promote cell cycle progression by further inhibiting the expression in genes encoding p21 and p27, which we have shown in the present study to be decreased in the highly proliferative PH-/IPAH-Fibs. It is also important to note that RNA-binding proteins are known to be regulators of gene expression in response to numerous stresses such as hypoxia. 76 PTBs, including PTBP1, have been demonstrated to associate with mRNAs encoding hypoxia-response proteins such as HIF to modulate their expression under hypoxic and other stressful conditions and to play major roles in establishing a hypoxic gene expression pattern. 77 It will be thus important to define mechanisms controlling HIF2α, the activated adventitial fibroblast.
Adventitial fibroblasts are increasingly recognized to play important roles in orchestrating inflammatory responses in the vessel wall. [8] [9] [10] 78 Our previous studies have documented that the activated PH-Fibs exhibit a stable proinflammatory phenotype, characterized by high expression levels of cytokines and chemokines including MCP-1. 13 MCP-1 is one of the key chemokines that is known to regulate migration and infiltration of monocytes and macrophages, both of which are increasingly thought to play key roles in the pathogenesis of pulmonary vascular disease in humans and animal models. 10, 39 Because MCP-1 is known to be produced in various cell types, it is important to understand the mechanisms that regulate MCP-1 production specifically in adventitial fibroblasts, as regulation could occur in a cell-specific way. 79 Our data show that production of MCP-1 by PH-/IPAH-Fibs is under the direct control of miR-124, consistent with studies in synoviocytes from patients with rheumatoid arthritis. 35 Our data also support previous observations demonstrating that HDAC inhibitors have beneficial antiinflammatory effects in animal models of inflammatory fibrotic vascular diseases and cancer. 13, 41, 80 Taken together, these observations suggest that targeting the acetylation state of miR-124, through the use of HDAC inhibitors, is a potentially effective approach to abrogating fibroblast activation.
In conclusion, decreased miR-124 expression directly contributes to the constitutively activated phenotype of adventitial fibroblasts in the hypertensive pulmonary vasculature. Our data support the idea that targeting miR-124 directly or indirectly with specific HDAC inhibitors or agents affecting alternative splicing factors (PTBP1) should be pursued for the pharmacological treatment of PH. 
